EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
IVDA
Iveda Solutions, Inc.
There isn't enough reported data to score IVDA yet.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
IVDA Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
IVDA's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
IVDA PE Valuation
IVDA has no meaningful PE right now: it lost money over the past year.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
IVDA Forward outlook
There aren't enough analyst estimates for IVDA to show an outlook.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
IVDA has the stronger earnings trend. Trailing diluted EPS is down 224% for EOSE versus IVDA down 138%.
IVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.53 | +$0.88 |
| Q1 2026 | -$0.66 | +$0.79 |
| Q4 2025 | -$0.88 | +$0.85 |
| Q3 2025 | -$1.22 | +$0.32 |
| Q2 2025 | -$1.41 | +$0.27 |
| Q1 2025 | -$1.45 | +$0.39 |
| Q4 2024 | -$1.73 | -$0.13 |
| Q3 2024 | -$1.54 | +$0.06 |
IVDA is still losing money, but far less than before: $0.53 per share over the past year, against $8.32 at its worst in early 2016.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over IVDA on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
IVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $801.8K | -48% |
| Q1 2026 | $1.5M | +1.3% |
| Q4 2025 | $626K | -64% |
| Q3 2025 | $1.7M | -31% |
| Q2 2025 | $1.5M | -0.4% |
| Q1 2025 | $1.5M | +325% |
| Q4 2024 | $1.7M | +70% |
| Q3 2024 | $2.4M | +175% |
IVDA's revenue has slid since its 2024 peak: $801,846 last quarter, down 48% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -89% | -54 points |
| Q1 2026 | -38% | +19 points |
| Q4 2025 | -263% | -160 points |
| Q3 2025 | -13% | +12 points |
| Q2 2025 | -35% | -1.3 points |
| Q1 2025 | -57% | +278 points |
| Q4 2024 | -103% | +7.4 points |
| Q3 2024 | -25% | +79 points |
IVDA has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
IVDA has the stronger cash trend. Its trailing FCF is up 14% versus its history, compared with EOSE at down 140%.
IVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q1 2026 | -$927.1K | -$801.2K |
| Q3 2025 | -$317K | +$582.7K |
| Q2 2025 | -$1.3M | -$325.9K |
| Q1 2025 | -$126K | +$1.2M |
| Q4 2024 | -$1.2M | -$236.5K |
| Q3 2024 | -$899.7K | +$2M |
| Q2 2024 | -$1M | -342% |
| Q1 2024 | -$1.3M | -$1.3M |
IVDA has burned cash in almost every quarter: −$3M over the past year, against −$4M the year before.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has the edge over IVDA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
IVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +32% | +2.9M shares |
| 1 year | +317% | +9M shares |
| 3 years | +519% | +9.9M shares |
| 5 years | +1212% | +10.9M shares |
| Available history | +2594% | +11.4M shares |
IVDA has 12M diluted shares, up 317% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
IVDA Net Leverage
IVDA's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
IVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.2 | Neutral |
| Stochastic | 4.0 | Oversold |
IVDA's weekly RSI is 37 (neutral) and its Stochastic is 4 (oversold).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
IVDA PE vs Industrials Sector
IVDA has no meaningful PE right now: it lost money over the past year.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
IVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.24 | 17% below |
| 20 week MA | $0.28 | 29% below |
| 50 week MA | $0.42 | 52% below |
| 100 week MA | $1.35 | 85% below |
| 200 week MA | $3.78 | 95% below |
IVDA is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
IVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $21.8 | $32.0 | +47% |
| 2021 | $32.0 | $128.6 | +302% |
| 2022 | $128.6 | $4.64 | -96% |
| 2023 | $4.64 | $5.07 | +9.3% |
| 2024 | $5.07 | $5.53 | +9.1% |
| 2025 | $5.53 | $0.89 | -84% |
| 2026 YTD | $0.89 | $0.20 | -78% |
IVDA has the edge over EOSE on returns for 2026, with the stronger performance.